Filing metadata

Accession number
0001867096-26-000105
Form type
Form 4
Filer
Xeris Biopharma Holdings, Inc.
CIK
CIK 1867096
Filed
Nov 04, 2026
Reporting period
Nov 02, 2026
Description
Insider transaction

Explore SEC Filings Hub